POLYMEROPOULOS MIHAEL HRISTOS 1355537 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Polymeropoulos Mihael Hristos | PRESIDENT AND CEO, CHAIRMAN OF THE BOARD | acq | 450000.0 | 23.35 | 78.21 | 0.0 | Direct | Common Stock | VANDA PHARMACEUTICALS INC. | code A | 1926902.0 | 57.54 (VNDA) |
2024-03-06 | 2024-03-04 | 2024-03-04 to 2024-03-05 | 4 | Polymeropoulos Mihael Hristos | PRESIDENT AND CEO, CHAIRMAN OF THE BOARD | dsp | 55172.0 | 2.86 | 9.59 | 4.19 | Direct | Common Stock | VANDA PHARMACEUTICALS INC. | code S | 1871730.0 | 57.54 (VNDA) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
---|
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)